Report cover image

Global Nifedipine API Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published May 17, 2025
Length 191 Pages
SKU # APRC20361320

Description

Summary

According to APO Research, The global Nifedipine API market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nifedipine API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nifedipine API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Nifedipine API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nifedipine API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nifedipine API include Bayer AG, Cipla Ltd, Delmar Chemicals Inc., Dipharma Francis S.r.l, Moehs Iberica S.L., Sumika Fine Chemicals Co. Ltd., Tecoland Corp, Teva Pharmaceuticals and Siyao Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nifedipine API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Nifedipine API, also provides the sales of main regions and countries. Of the upcoming market potential for Nifedipine API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nifedipine API sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Nifedipine API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Nifedipine API sales, projected growth trends, production technology, application and end-user industry.

Nifedipine API Segment by Company

Bayer AG
Cipla Ltd
Delmar Chemicals Inc.
Dipharma Francis S.r.l
Moehs Iberica S.L.
Sumika Fine Chemicals Co. Ltd.
Tecoland Corp
Teva Pharmaceuticals
Siyao Pharmaceuticals
Xiyue Pharmaceutical
Zhong'an Pharmaceutical
Yantai Luyin Pharmaceutical
Qingyang Pharmaceutical
Nifedipine API Segment by Type

98% Nifedipine API
99% Nifedipine API
99.9% Nifedipine API
Nifedipine API Segment by Application

Nifedipine Controlled Release Tablets
Nifedipine Extended Release Tablets
Nifedipine API Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nifedipine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Nifedipine API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Nifedipine API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nifedipine API sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Nifedipine API Market by Type
1.2.1 Global Nifedipine API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 98% Nifedipine API
1.2.3 99% Nifedipine API
1.2.4 99.9% Nifedipine API
1.3 Nifedipine API Market by Application
1.3.1 Global Nifedipine API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Nifedipine Controlled Release Tablets
1.3.3 Nifedipine Extended Release Tablets
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Nifedipine API Market Dynamics
2.1 Nifedipine API Industry Trends
2.2 Nifedipine API Industry Drivers
2.3 Nifedipine API Industry Opportunities and Challenges
2.4 Nifedipine API Industry Restraints
3 Global Market Growth Prospects
3.1 Global Nifedipine API Revenue Estimates and Forecasts (2020-2031)
3.2 Global Nifedipine API Revenue by Region
3.2.1 Global Nifedipine API Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Nifedipine API Revenue by Region (2020-2025)
3.2.3 Global Nifedipine API Revenue by Region (2026-2031)
3.2.4 Global Nifedipine API Revenue Market Share by Region (2020-2031)
3.3 Global Nifedipine API Sales Estimates and Forecasts 2020-2031
3.4 Global Nifedipine API Sales by Region
3.4.1 Global Nifedipine API Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Nifedipine API Sales by Region (2020-2025)
3.4.3 Global Nifedipine API Sales by Region (2026-2031)
3.4.4 Global Nifedipine API Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Nifedipine API Revenue by Manufacturers
4.1.1 Global Nifedipine API Revenue by Manufacturers (2020-2025)
4.1.2 Global Nifedipine API Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Nifedipine API Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Nifedipine API Sales by Manufacturers
4.2.1 Global Nifedipine API Sales by Manufacturers (2020-2025)
4.2.2 Global Nifedipine API Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Nifedipine API Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Nifedipine API Sales Price by Manufacturers (2020-2025)
4.4 Global Nifedipine API Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Nifedipine API Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Nifedipine API Manufacturers, Product Type & Application
4.7 Global Nifedipine API Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Nifedipine API Market CR5 and HHI
4.8.2 2024 Nifedipine API Tier 1, Tier 2, and Tier 3
5 Nifedipine API Market by Type
5.1 Global Nifedipine API Revenue by Type
5.1.1 Global Nifedipine API Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Nifedipine API Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Nifedipine API Revenue Market Share by Type (2020-2031)
5.2 Global Nifedipine API Sales by Type
5.2.1 Global Nifedipine API Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Nifedipine API Sales by Type (2020-2031) & (K Tons)
5.2.3 Global Nifedipine API Sales Market Share by Type (2020-2031)
5.3 Global Nifedipine API Price by Type
6 Nifedipine API Market by Application
6.1 Global Nifedipine API Revenue by Application
6.1.1 Global Nifedipine API Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Nifedipine API Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Nifedipine API Revenue Market Share by Application (2020-2031)
6.2 Global Nifedipine API Sales by Application
6.2.1 Global Nifedipine API Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Nifedipine API Sales by Application (2020-2031) & (K Tons)
6.2.3 Global Nifedipine API Sales Market Share by Application (2020-2031)
6.3 Global Nifedipine API Price by Application
7 Company Profiles
7.1 Bayer AG
7.1.1 Bayer AG Comapny Information
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Bayer AG Nifedipine API Product Portfolio
7.1.5 Bayer AG Recent Developments
7.2 Cipla Ltd
7.2.1 Cipla Ltd Comapny Information
7.2.2 Cipla Ltd Business Overview
7.2.3 Cipla Ltd Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Cipla Ltd Nifedipine API Product Portfolio
7.2.5 Cipla Ltd Recent Developments
7.3 Delmar Chemicals Inc.
7.3.1 Delmar Chemicals Inc. Comapny Information
7.3.2 Delmar Chemicals Inc. Business Overview
7.3.3 Delmar Chemicals Inc. Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Delmar Chemicals Inc. Nifedipine API Product Portfolio
7.3.5 Delmar Chemicals Inc. Recent Developments
7.4 Dipharma Francis S.r.l
7.4.1 Dipharma Francis S.r.l Comapny Information
7.4.2 Dipharma Francis S.r.l Business Overview
7.4.3 Dipharma Francis S.r.l Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Dipharma Francis S.r.l Nifedipine API Product Portfolio
7.4.5 Dipharma Francis S.r.l Recent Developments
7.5 Moehs Iberica S.L.
7.5.1 Moehs Iberica S.L. Comapny Information
7.5.2 Moehs Iberica S.L. Business Overview
7.5.3 Moehs Iberica S.L. Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Moehs Iberica S.L. Nifedipine API Product Portfolio
7.5.5 Moehs Iberica S.L. Recent Developments
7.6 Sumika Fine Chemicals Co. Ltd.
7.6.1 Sumika Fine Chemicals Co. Ltd. Comapny Information
7.6.2 Sumika Fine Chemicals Co. Ltd. Business Overview
7.6.3 Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Sumika Fine Chemicals Co. Ltd. Nifedipine API Product Portfolio
7.6.5 Sumika Fine Chemicals Co. Ltd. Recent Developments
7.7 Tecoland Corp
7.7.1 Tecoland Corp Comapny Information
7.7.2 Tecoland Corp Business Overview
7.7.3 Tecoland Corp Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Tecoland Corp Nifedipine API Product Portfolio
7.7.5 Tecoland Corp Recent Developments
7.8 Teva Pharmaceuticals
7.8.1 Teva Pharmaceuticals Comapny Information
7.8.2 Teva Pharmaceuticals Business Overview
7.8.3 Teva Pharmaceuticals Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Teva Pharmaceuticals Nifedipine API Product Portfolio
7.8.5 Teva Pharmaceuticals Recent Developments
7.9 Siyao Pharmaceuticals
7.9.1 Siyao Pharmaceuticals Comapny Information
7.9.2 Siyao Pharmaceuticals Business Overview
7.9.3 Siyao Pharmaceuticals Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Siyao Pharmaceuticals Nifedipine API Product Portfolio
7.9.5 Siyao Pharmaceuticals Recent Developments
7.10 Xiyue Pharmaceutical
7.10.1 Xiyue Pharmaceutical Comapny Information
7.10.2 Xiyue Pharmaceutical Business Overview
7.10.3 Xiyue Pharmaceutical Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Xiyue Pharmaceutical Nifedipine API Product Portfolio
7.10.5 Xiyue Pharmaceutical Recent Developments
7.11 Zhong'an Pharmaceutical
7.11.1 Zhong'an Pharmaceutical Comapny Information
7.11.2 Zhong'an Pharmaceutical Business Overview
7.11.3 Zhong'an Pharmaceutical Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Zhong'an Pharmaceutical Nifedipine API Product Portfolio
7.11.5 Zhong'an Pharmaceutical Recent Developments
7.12 Yantai Luyin Pharmaceutical
7.12.1 Yantai Luyin Pharmaceutical Comapny Information
7.12.2 Yantai Luyin Pharmaceutical Business Overview
7.12.3 Yantai Luyin Pharmaceutical Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Yantai Luyin Pharmaceutical Nifedipine API Product Portfolio
7.12.5 Yantai Luyin Pharmaceutical Recent Developments
7.13 Qingyang Pharmaceutical
7.13.1 Qingyang Pharmaceutical Comapny Information
7.13.2 Qingyang Pharmaceutical Business Overview
7.13.3 Qingyang Pharmaceutical Nifedipine API Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Qingyang Pharmaceutical Nifedipine API Product Portfolio
7.13.5 Qingyang Pharmaceutical Recent Developments
8 North America
8.1 North America Nifedipine API Market Size by Type
8.1.1 North America Nifedipine API Revenue by Type (2020-2031)
8.1.2 North America Nifedipine API Sales by Type (2020-2031)
8.1.3 North America Nifedipine API Price by Type (2020-2031)
8.2 North America Nifedipine API Market Size by Application
8.2.1 North America Nifedipine API Revenue by Application (2020-2031)
8.2.2 North America Nifedipine API Sales by Application (2020-2031)
8.2.3 North America Nifedipine API Price by Application (2020-2031)
8.3 North America Nifedipine API Market Size by Country
8.3.1 North America Nifedipine API Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Nifedipine API Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Nifedipine API Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Nifedipine API Market Size by Type
9.1.1 Europe Nifedipine API Revenue by Type (2020-2031)
9.1.2 Europe Nifedipine API Sales by Type (2020-2031)
9.1.3 Europe Nifedipine API Price by Type (2020-2031)
9.2 Europe Nifedipine API Market Size by Application
9.2.1 Europe Nifedipine API Revenue by Application (2020-2031)
9.2.2 Europe Nifedipine API Sales by Application (2020-2031)
9.2.3 Europe Nifedipine API Price by Application (2020-2031)
9.3 Europe Nifedipine API Market Size by Country
9.3.1 Europe Nifedipine API Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Nifedipine API Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Nifedipine API Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Nifedipine API Market Size by Type
10.1.1 China Nifedipine API Revenue by Type (2020-2031)
10.1.2 China Nifedipine API Sales by Type (2020-2031)
10.1.3 China Nifedipine API Price by Type (2020-2031)
10.2 China Nifedipine API Market Size by Application
10.2.1 China Nifedipine API Revenue by Application (2020-2031)
10.2.2 China Nifedipine API Sales by Application (2020-2031)
10.2.3 China Nifedipine API Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Nifedipine API Market Size by Type
11.1.1 Asia Nifedipine API Revenue by Type (2020-2031)
11.1.2 Asia Nifedipine API Sales by Type (2020-2031)
11.1.3 Asia Nifedipine API Price by Type (2020-2031)
11.2 Asia Nifedipine API Market Size by Application
11.2.1 Asia Nifedipine API Revenue by Application (2020-2031)
11.2.2 Asia Nifedipine API Sales by Application (2020-2031)
11.2.3 Asia Nifedipine API Price by Application (2020-2031)
11.3 Asia Nifedipine API Market Size by Country
11.3.1 Asia Nifedipine API Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Nifedipine API Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Nifedipine API Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Nifedipine API Market Size by Type
12.1.1 SAMEA Nifedipine API Revenue by Type (2020-2031)
12.1.2 SAMEA Nifedipine API Sales by Type (2020-2031)
12.1.3 SAMEA Nifedipine API Price by Type (2020-2031)
12.2 SAMEA Nifedipine API Market Size by Application
12.2.1 SAMEA Nifedipine API Revenue by Application (2020-2031)
12.2.2 SAMEA Nifedipine API Sales by Application (2020-2031)
12.2.3 SAMEA Nifedipine API Price by Application (2020-2031)
12.3 SAMEA Nifedipine API Market Size by Country
12.3.1 SAMEA Nifedipine API Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Nifedipine API Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Nifedipine API Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Nifedipine API Value Chain Analysis
13.1.1 Nifedipine API Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Nifedipine API Production Mode & Process
13.2 Nifedipine API Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Nifedipine API Distributors
13.2.3 Nifedipine API Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.